Summary: The FDA-approved Alzheimer’s drug donanemab is under scrutiny due to concerns about its effectiveness and safety, according to an investigation. The study highlights multiple patient deaths during trials, design…
Tag: BMJ
High-Dose Psilocybin Shows Potential as an Antidepressant Treatment
Summary: A meta-analysis suggests that high doses of psilocybin may alleviate depressive symptoms similarly to the SSRI drug escitalopram. While the effect size was small, psilocybin outperformed placebo in clinical…
Loud Play, Silent Risk: Video Gaming’s Link to Hearing Loss
Summary: A systematic review indicates a potential risk of irreversible hearing loss and tinnitus among video gamers due to high sound levels. The study, encompassing over 50,000 individuals, found that…
